Skip to main content
Equibles

Rafferty Asset Management, LLC

Position in SMMT — Summit Therapeutics Inc.

CIK 1389426 New York, NY
Back to SMMT Full portfolio

Position in SMMT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$3,010,526
-$1,901,517 QoQ
Shares Held
206,625
-20.2% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#58
of 242 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SMMT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Rafferty Asset Management, LLC holds $335,902,097 across 164 Biotechnology names. SMMT ranks #44 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 65,798 $32,683,840
2 REGN
Regeneron Pharmaceuticals, Inc.
 38,534 $24,027,490
3 ALNY
Alnylam Pharmaceuticals, Inc.
 55,332 $16,656,591
4 MRNA
Moderna, Inc.
 111,906 $7,836,777
5 INCY
Incyte Corp
 44,663 $5,062,997
6 APGE
Apogee Therapeutics, Inc.
 33,369 $4,429,067
7 TWST
Twist Bioscience Corp
 40,732 $4,190,508
8 ORKA
Oruka Therapeutics, Inc.
 43,110 $4,102,778

All Filings in SMMT

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,010,526 206,625
2026-03-31 $4,912,043 259,074
2025-12-31 $5,033,796 287,810
2025-09-30 $7,007,376 339,176
2025-06-30 $4,231,591 198,853
2025-03-31 $4,431,723 229,742
2024-12-31 $5,562,143 311,692
2024-09-30 $2,372,098 108,315
2024-06-30 $1,294,004 165,898
2024-03-31 $2,692,184 650,286